Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02591082 · ClinicalTrials.gov registry record
Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter
A clinical trial, sponsored by RenovoRx.
- Completed
- Registry status
- 25
- Enrollment target
NCT02591082 is a clinical trial that has completed, run by RenovoRx. The registered enrollment target is 25 participants.
The verdict
NCT02591082 has completed, sponsored by RenovoRx.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This is an observational study to assess patient survival and clinical outcomes after the RenovoCath™ RC120 catheter is used to deliver chemotherapeutic agents to pancreatic tumors.
Interventions
- DEVICE RenovoCath™ R120 Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2015-12 |
| Est. Completion | 2021-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02591082
The ClinicalTrials.gov registry entry for NCT02591082 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is RenovoRx, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RenovoCath™ R120 Catheter is the first listed.
NCT02591082 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02591082 about?
NCT02591082 is a clinical study titled "Intra-Arterial Treatment of Pancreatic Cancer Using the RenovoCath™ RC120 Catheter". This is an observational study to assess patient survival and clinical outcomes after the RenovoCath™ RC120 catheter is used to deliver chemotherapeutic agents to pancreatic tumors.
What is the current status of trial NCT02591082?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2015-12. Estimated completion is 2021-02-26.
What interventions are being tested in trial NCT02591082?
The interventions under investigation include: RenovoCath™ R120 Catheter (DEVICE).
Who is sponsoring clinical trial NCT02591082?
This trial is sponsored by RenovoRx, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.